HIV/AIDS Press Releases

April 30, 2008
Earvin "Magic" Johnson and Abbott Bring "I Stand With Magic Program," Part of the "Campaign to End Black HIV/AIDS" to Washington, D.C.

April 10, 2008
New Abbott Kaletra® (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe

February 26, 2008
Earvin "Magic" Johnson and Abbott Bring "I Stand With Magic Program: Part of the Campaign to End Black HIV/AIDS" to Miami

January 28, 2008
Abbott's Kaletra® and Aluvia® (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA

December 1, 2007
Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet

December 1, 2007
Cookie Johnson and Abbott Bring "I Stand With Magic: Campaign to End Black AIDS" to Los Angeles to Educate African-American Women on HIV/AIDS

November 30, 2007
The Magic Johnson Foundation and Abbott Expand Focus of 'Campaign to End Black AIDS' to African-American Women in 2008

November 14, 2007
Abbott Update to Statement on the Filing in Thailand of the Lower-strength Kaletra/Aluvia® Tablet Suitable for Pediatric Use

July 27, 2007
Abbott Statement: Kaletra Pediatric Tablet Filing in Thailand

July, 25, 2007
Abbott's New Aluvia® (lopinavir/ritonavir) Tablet Approved in Nineteen African Countries

July 20, 2007
Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra® and Aluvia® (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS

July 17, 2007
Studies Confirm Rise of HIV Variant Strains in the United States and Importance of Reliable Viral Load Testing

July 5, 2007
Abbott and Government of Brazil Sign Kaletra® (lopinavir/ritonavir) Supply Agreement

June 27, 2007
Abbott and Abbott Fund Expand Commitment to Improving Health Care in Tanzania With Dedication of New Lab and Launch of New Diagnostic Programs

June 13, 2007
Global Business Coalition on HIV/AIDS, TB and Malaria (GBC) Honors Abbott and Abbott Fund for Efforts to Fight HIV/AIDS in Tanzania

May 29, 2007
Abbott Fund Increases Commitment to Fight Against HIV/AIDS in Tanzania, Opening Country's First Corporate Foundation Office

May 25, 2007
Abbott Statement: Status of Lopinavir/Ritonavir in Thailand

April 10, 2007
Abbott Agrees with World Health Organization (WHO) Director-General to Expand Access to Kaletra/Aluvia (lopinavir/ritonavir)

January 8, 2007
Abbott m2000™ Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada

December 1, 2006
Earvin "Magic" Johnson and Abbott Announce Major Initiative on World Aids Day to Help Reduce New HIV/AIDS Infections Among African Americans

November 28, 2006
Children Affected by HIV/AIDS Around the World Bring Their Photographs and Stories to Chicago For the First Time

November 2, 2006
Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-infected Children of Malawi

August 13, 2006
Abbott Statement Regarding New Initiatives to Expand Access and Affordability to lopinavir/ritonavir in the Developing World

July 3, 2006
Abbott's New Tablet Formulation of Kaletra® (lopinavir/ritonavir) Approved in Europe

April 7, 2006
Abbott and Earvin "Magic" Johnson Announce Partnership

April 4, 2006
Abbott Files for Registration of Innovative Formulation for the Treatment of HIV in South Africa

March 13, 2006
Abbott Statement on Advancing Pediatric HIV Treatment in Developing Countries